In a flu pandemic setting, the drug could be used to curb household transmission, especially early in the response, the authors say.
The loss of activity is equivalent to 15% of the US population becoming completely immobile for 1 day.
Adult COVID-19 patients also infected with the flu are 4 times more likely to need mechanical ventilation and 2.4 times more likely to die.
The roadmap offers a powerful opportunity to leverage advances in vaccine science to better protect against influenza, including pandemic flu.
The Influenza Vaccines Roadmaps Initiative newsletter highlights recent news, research, and events pertaining to influenza vaccine R&D.
A database of novel vaccine candidates that are designed to provide broader and more durable protection against influenza viruses.
Help support our work on influenza. Advance the work of CIDRAP in public health preparedness and emerging infectious disease response.
Receive the latest infectious disease information.
(CIDRAP News) – Researchers relying on mathematical modeling claim that early containment of pandemic influenza, an eventuality widely accepted as not an "if" but a "when," may well be attainable through targeted public health strategies. A leading public health expert, however, cautions against viewing these study results as fodder for relaxed planning efforts, stressing the myriad variables that would come into play.
(CIDRAP News) A large-scale study of genetic data on influenza shows that viruses of the same strain or serotype have more genetic differences than previously suspected and can exchange genetic material in ways that make them more infectious.
(CIDRAP News) – Pandemic influenza could kill 540,000 Americans and sicken up to 66.9 million, according to a recent report by the nonprofit organization Trust for America's Health (TFAH).
(CIDRAP News) About 5,000 migratory birds have died of avian influenza at a wildlife sanctuary in northwestern China, close to five times as many as reported previously, United Nations officials who visited the site said today.
(CIDRAP News) A refrigerated form of MedImmunes FluMist intranasal influenza vaccine has been shown to be as effective as the standard frozen form in stimulating the immune system, the company says.
(CIDRAP News) International health agencies are questioning China about a report that the country has used a human antiviral drug in poultry for years, thereby causing the H5N1 influenza virus to become resistant to the drug.
(CIDRAP News) The Infectious Diseases Society of America (IDSA) is calling the US government's stockpile of antiviral drugs "totally inadequate" in the face of a potential influenza pandemic.
(CIDRAP News) – Chiron Corp. has announced it won't be able to provide as many influenza vaccine doses as previously estimated for the coming flu season, fraying a thread in the nation's fragile vaccine supply web.
Chiron expects to supply 18 million to 26 million doses of flu vaccine in the United States this year, instead of the 25 million to 30 million doses projected in April, the company said in a news release yesterday.
(CIDRAP News) Colorado's new system for tracking hospital admissions related to influenza is a potential model for measuring the burden of serious flu complications and the severity of flu seasons, the Centers for Disease Control and Prevention (CDC) said today.
(CIDRAP News) Resveratrol, a chemical found in grapes and other fruits, inhibits the reproduction of influenza viruses in cell culture and mice, according to a recent report in the Journal of Infectious Diseases.
